Risk factor
Very high price volatility
Profitability factor
Very favourable analyst view
About
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overvalued on P/FCF.
Target Price
The average target price of BLFS is 33 and suggests 48% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell